During aging, hematopoietic stem cells (HSCs) are able to function normally under homeostatic conditions but are unable to mount effective regenerative responses under conditions of acute damage. Thus, in response to bleeding, infection or chemotherapy, elderly people often fail to replenish their blood effectively, and have an increased risk of hematopoietic disorders such as anemia and neutropenia that can often be fatal. To understand why this hematopoietic dysfunction occurs during aging, it is important to identify the molecular mechanisms that allow young HSCs to respond to acute damage and determine how these mechanisms fail in the aging hematopoietic system. To understand the molecular signals that normally allow the effective regeneration of the blood, we have studied animals treated with the chemotherapeutic drug Cyclophosphamide (Cy) and the growth factor G-CSF which causes an acute loss of proliferating progenitors in the bone marrow followed by expansion of HSCs to regenerate the progenitor pool. Using this as a damage model, we have found that that the Wnt signaling is sharply upregulated in a large fraction of HSCs responding to Cy/G-CSF suggesting that Wnt signaling may be a critical mediator of HSC regeneration after damage. In order to test this hypothesis, we now propose to define the significance of Wnt activation in regenerating HSCs and determine if this activity changes as HSCs age. Identifying the mechanisms that underlie the regenerative response to Cyclophosphamide/ G-CSF treatment will enhance our ability to harvest and expand stem cells for transplantation therapy. Furthermore, understanding the basis of impaired regeneration in the aging hematopoietic system may allow us to design novel means to improve the health and quality of life of aging patients. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK072234-02
Application #
7216958
Study Section
Hematopoiesis Study Section (HP)
Program Officer
Wright, Daniel G
Project Start
2006-05-15
Project End
2010-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
2
Fiscal Year
2007
Total Cost
$310,360
Indirect Cost
Name
Duke University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Koechlein, Claire S; Harris, Jeffrey R; Lee, Timothy K et al. (2016) High-resolution imaging and computational analysis of haematopoietic cell dynamics in vivo. Nat Commun 7:12169
Fereshteh, Mark; Ito, Takahiro; Kovacs, Jeffrey J et al. (2012) ?-Arrestin2 mediates the initiation and progression of myeloid leukemia. Proc Natl Acad Sci U S A 109:12532-7
Ito, Takahiro; Kwon, Hyog Young; Zimdahl, Bryan et al. (2010) Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature 466:765-8
Zhao, Chen; Chen, Alan; Jamieson, Catriona H et al. (2009) Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458:776-9
Congdon, Kendra L; Reya, Tannishtha (2008) Divide and conquer: how asymmetric division shapes cell fate in the hematopoietic system. Curr Opin Immunol 20:302-7
Congdon, Kendra L; Voermans, Carlijn; Ferguson, Emily C et al. (2008) Activation of Wnt signaling in hematopoietic regeneration. Stem Cells 26:1202-10
Wu, Mingfu; Kwon, Hyog Young; Rattis, Frederique et al. (2007) Imaging hematopoietic precursor division in real time. Cell Stem Cell 1:541-54
Zhao, Chen; Blum, Jordan; Chen, Alan et al. (2007) Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 12:528-41
DiMascio, Leah; Voermans, Carlijn; Uqoezwa, Mweia et al. (2007) Identification of adiponectin as a novel hemopoietic stem cell growth factor. J Immunol 178:3511-20